Works matching IS 03008126 AND DT 2023 AND VI 51 AND IP 5


Results: 41
    1

    Strongyloides stercoralis infection: an underlying cause of invasive bacterial infections of enteric origin. Results from a prospective cross-sectional study of a northern Italian tertiary hospital.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1541, doi. 10.1007/s15010-023-02072-1
    By:
    • Gardini, Giulia;
    • Froeschl, Guenter;
    • Gurrieri, Francesca;
    • De Francesco, Maria Antonia;
    • Cattaneo, Chiara;
    • Marchese, Valentina;
    • Piccinelli, Giorgio;
    • Corbellini, Silvia;
    • Pagani, Chiara;
    • Santagiuliana, Marzia;
    • Fumarola, Benedetta;
    • Gulletta, Maurizio;
    • Perandin, Francesca;
    • Castelli, Francesco;
    • Matteelli, Alberto
    Publication type:
    Article
    2
    3
    4
    5
    6

    SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1531, doi. 10.1007/s15010-023-02052-5
    By:
    • Engels, Geraldine;
    • Oechsle, Anna-Lisa;
    • Schlegtendal, Anne;
    • Maier, Christoph;
    • Holzwarth, Sarah;
    • Streng, Andrea;
    • Lange, Berit;
    • Karch, Andre;
    • Petersmann, Astrid;
    • Streeck, Hendrik;
    • Blaschke-Steinbrecher, Sabine;
    • Härtel, Christoph;
    • Schroten, Horst;
    • von Kries, Rüdiger;
    • Berner, Reinhard;
    • Liese, Johannes;
    • Brinkmann, Folke;
    • Toepfner, Nicole;
    • the IMMUNEBRIDGE KIDS study group;
    • Forster, Johannes
    Publication type:
    Article
    7
    9

    Tecovirimat for the treatment of severe Mpox in Germany.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1563, doi. 10.1007/s15010-023-02049-0
    By:
    • Hermanussen, Lennart;
    • Brehm, Thomas Theo;
    • Wolf, Timo;
    • Boesecke, Christoph;
    • Schlabe, Stefan;
    • Borgans, Frauke;
    • Monin, Malte B.;
    • Jensen, Björn-Erik Ole;
    • Windhaber, Stefan;
    • Scholten, Stefan;
    • Jordan, Sabine;
    • Lütgehetmann, Marc;
    • Wiesch, Julian Schulze zur;
    • Addo, Marylyn M.;
    • Mikolajewska, Agata;
    • Niebank, Michaela;
    • Schmiedel, Stefan
    Publication type:
    Article
    10

    Short report: impact of selective reporting of antibiotic susceptibility testing on antibiotic use in patients with bloodstream infection with Enterococcus faecalis.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1557, doi. 10.1007/s15010-023-02045-4
    By:
    • Geismann, Florian;
    • Handschuh, Stefan;
    • Malfertheiner, Maximilian;
    • Salzberger, Bernd;
    • Bauernfeind, Stilla;
    • Hitzenbichler, Florian;
    • Simon, Michaela;
    • Caplunik-Pratsch, Aila;
    • Schneider-Brachert, Wulf;
    • Wiest, Clemens;
    • Ruegamer, Tamara;
    • Mohr, Arno
    Publication type:
    Article
    11
    12

    Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1577, doi. 10.1007/s15010-023-02039-2
    By:
    • Franceschini, Erica;
    • Pellegrino, Mariachiara;
    • Todisco, Vera;
    • Dolci, Giovanni;
    • Bettelli, Francesca;
    • Meschiari, Marianna;
    • Bedini, Andrea.;
    • Fregni-Serpini, Giulia;
    • Grottola, Antonella;
    • Guaraldi, Giovanni;
    • Pecorari, Monica;
    • Sarti, Mario;
    • Luppi, Mario;
    • Perno, Carlo Federico;
    • Mussini, Cristina
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case–control and molecular source attribution study (SwissLEGIO).

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1467, doi. 10.1007/s15010-023-02014-x
    By:
    • Fischer, Fabienne B.;
    • Bigler, Melina;
    • Mäusezahl, Daniel;
    • Hattendorf, Jan;
    • Egli, Adrian;
    • Julian, Timothy R.;
    • Rölli, Franziska;
    • Gaia, Valeria;
    • Wymann, Monica;
    • Fridez, Françoise;
    • Bertschi, Stefanie;
    • The SwissLEGIO Hospital Network;
    • Akers, Isabel;
    • Albrich, Werner C.;
    • Bandeira, Diane;
    • Bernasconi, Enos;
    • Berthod, Delphine;
    • Boesing, Maria;
    • Calligaris-Maibach, Romana;
    • Clerc, Olivier
    Publication type:
    Article
    24

    Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1453, doi. 10.1007/s15010-023-02011-0
    By:
    • Tancredi, Stefano;
    • Chiolero, Arnaud;
    • Wagner, Cornelia;
    • Haller, Moa Lina;
    • Chocano-Bedoya, Patricia;
    • Ortega, Natalia;
    • Rodondi, Nicolas;
    • Kaufmann, Laurent;
    • Lorthe, Elsa;
    • Baysson, Hélène;
    • Stringhini, Silvia;
    • Michel, Gisela;
    • Lüdi, Chantal;
    • Harju, Erika;
    • Frank, Irene;
    • Imboden, Medea;
    • Witzig, Melissa;
    • Keidel, Dirk;
    • Probst-Hensch, Nicole;
    • Amati, Rebecca
    Publication type:
    Article
    25
    26
    27
    28

    Diabetes mellitus is associated with 90-day mortality in old critically ill COVID-19 patients: a multicenter prospective observational cohort study.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1407, doi. 10.1007/s15010-023-02001-2
    By:
    • Mayerhöfer, Timo;
    • Klein, Sebastian;
    • Wernly, Bernhard;
    • Flaatten, Hans;
    • Guidet, Bertrand;
    • De Lange, Dylan W.;
    • Fjølner, Jesper;
    • Leaver, Susannah;
    • Beil, Michael;
    • Sviri, Sigal;
    • Bruno, Raphael Romano;
    • Artigas, Antonio;
    • van Heerden, Peter Vernon;
    • Pinto, Bernardo Bollen;
    • Schefold, Joerg C.;
    • Moreno, Rui;
    • Cecconi, Maurizio;
    • Szczeklik, Wojciech;
    • Jung, Christian;
    • Joannidis, Michael
    Publication type:
    Article
    29
    30

    First detected geographical cluster of BoDV-1 encephalitis from same small village in two children: therapeutic considerations and epidemiological implications.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1383, doi. 10.1007/s15010-023-01998-w
    By:
    • Grosse, Leonie;
    • Lieftüchter, Victoria;
    • Vollmuth, Yannik;
    • Hoffmann, Florian;
    • Olivieri, Martin;
    • Reiter, Karl;
    • Tacke, Moritz;
    • Heinen, Florian;
    • Borggraefe, Ingo;
    • Osterman, Andreas;
    • Forstner, Maria;
    • Hübner, Johannes;
    • von Both, Ulrich;
    • Birzele, Lena;
    • Rohlfs, Meino;
    • Schomburg, Adrian;
    • Böhmer, Merle M.;
    • Ruf, Viktoria;
    • Cadar, Dániel;
    • Muntau, Birgit
    Publication type:
    Article
    31
    32

    Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1357, doi. 10.1007/s15010-023-01996-y
    By:
    • Jank, Marietta;
    • Oechsle, Anna-Lisa;
    • Armann, Jakob;
    • Behrends, Uta;
    • Berner, Reinhard;
    • Chao, Cho-Ming;
    • Diffloth, Natalie;
    • Doenhardt, Maren;
    • Hansen, Gesine;
    • Hufnagel, Markus;
    • Lander, Fabian;
    • Liese, Johannes G.;
    • Muntau, Ania C.;
    • Niehues, Tim;
    • von Both, Ulrich;
    • Verjans, Eva;
    • Weil, Katharina;
    • von Kries, Rüdiger;
    • Schroten, Horst
    Publication type:
    Article
    33

    Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19 and real-life impact of a computational signature on clinical decision-making: a prospective cohort study.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1349, doi. 10.1007/s15010-023-01993-1
    By:
    • Fröhlich, Franziska;
    • Gronwald, Benjamin;
    • Bay, Johannes;
    • Simon, Arne;
    • Poryo, Martin;
    • Geisel, Jürgen;
    • Tegethoff, Sina A.;
    • Last, Katharina;
    • Rissland, Jürgen;
    • Smola, Sigrun;
    • Becker, Sören L.;
    • Zemlin, Michael;
    • Meyer, Sascha;
    • Papan, Cihan
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.

    Published in:
    Infection, 2023, v. 51, n. 5, p. 1273, doi. 10.1007/s15010-022-01959-9
    By:
    • Johnson, Matthew G.;
    • Strizki, Julie M.;
    • Brown, Michelle L.;
    • Wan, Hong;
    • Shamsuddin, Hala H.;
    • Ramgopal, Moti;
    • Florescu, Diana F.;
    • Delobel, Pierre;
    • Khaertynova, Ilsiyar;
    • Flores, José F.;
    • Fouche, Leon F.;
    • Chang, Shan-Chwen;
    • Williams-Diaz, Angela;
    • Du, Jiejun;
    • Grobler, Jay A.;
    • Paschke, Amanda;
    • De Anda, Carisa
    Publication type:
    Article